Gene Therapy for Rare Disorders Europe
August 3, 2020
Meet Veristat at the Virtual event taking place 26-28 October 2020.
Webinar | Minimize Disruption of Your Oncology Trial
June 4, 2020
View the On-Demand Webinar
As the world begins to relax restrictions, what are the lessons learned that can catapult us into the next innovation in trial operations for good?View the On-Webinar
Submitting an Investigational New Drug (IND) application to the US FDA is a significant step in the development of a new drug or biologic product. But, are you ready?DIA 2020 Virtual Meeting ⎪Booth 138
February 19, 2020
Meet Veristat at the Virtual US DIA Annual Meeting 2020 taking place on 14-18 June 2020, Virtual Booth #138
ASCO Annual Meeting ⎪Booth 25110
February 19, 2020
Meet Veristat at the ASCO 2020, 30 May – 1 June 2020, Booth 25110
Chief Medical Officer Summit 2020 -Outsourcing Panel Discussion
February 19, 2020
Connect with Veristat at the CMO Summit, 26-27 October, 2020
Gene Therapy for Rare Disorders 2020 | Booth and Presentation
February 19, 2020
As of 11 March 2020- This event is being postponed until early 2020 due to Covid-19 Pandemic
Outsourcing in Clinical Trials West Coast 2020 | Booth #1
February 19, 2020
Meet Veristat at booth #1 at OCT West, 3-4 March 2020
Webinar | Achieving Balance in Clinical Trial Database Design: Considerations for Enhancing Clinical Trial Efficiency
November 14, 2019
Webinar Summary:
Designing a clinical trial database is a balancing act. Any clinical program has multiple stakeholders who have both short-term and long-term goals to achieve. A good database designer must understand the needs and goals of the sponsor and its various functional project team members. The designer must consider the ease of use for the clinical trial sites who will be entering the trial data, with the needs of the downstream stakeholders in biostatistics, programming, and medical writing. Additionally, we not only need to consider today’s priorities, we also must understand the overall strategy of the clinical program, especially as it moves forward past the current stage.